Large-cap Health Care company Teva Pharmaceutical Industries has logged a 2.4% change today on a trading volume of 937,409.

CVS Health has announced further leadership appointments as the healthcare giant navigates choppy financial waters. | CVS Health has announced further leadership appointments as the healthcare giant ...

According to a recent report by the European Commission on the application of competition rules, the pharmaceutical industry is under intense scrutiny, aimed at ensuring access to innovative and ...

Tonix appoints two executives with decades of experience successfully launching and commercializing new CNS products Bradley ...

CVS Health® (NYSE: CVS) today announced that Len Shankman will be president, Pharmacy and Consumer Wellness (PCW), reporting to Prem Shah, group president, CVS Health. In addition, the company ...

Intech Investment Management LLC purchased a new stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) in ...

Central to the burgeoning success of India’s generic drugs market are the supportive measures and initiatives implemented by the government. The “Make in India” policy spearheaded by the Indian ...

Swiss drugmaker Novartis will pay up to $2.9 billion for PTC Therapeutics' promising experimental drug for a neurological ...

Today, Benzinga's options scanner spotted 25 options trades for Teva Pharmaceutical Indus. This is not a typical pattern. The sentiment among these major traders is split, with 24% bullish and 60% ...

While antiviral drugs to treat HIV had been approved a decade earlier, only five out of 33 million people who carried the ...

Teva Pharmaceuticals "pivot to growth" strategy under CEO Richard Francis aims to use a combination of biosimilars, generics, ...